Cargando…
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151403/ https://www.ncbi.nlm.nih.gov/pubmed/32283128 http://dx.doi.org/10.1016/j.diabres.2020.108146 |
| _version_ | 1783521242376044544 |
|---|---|
| author | Pal, Rimesh Bhadada, Sanjay K. |
| author_facet | Pal, Rimesh Bhadada, Sanjay K. |
| author_sort | Pal, Rimesh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7151403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71514032020-04-13 Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Pal, Rimesh Bhadada, Sanjay K. Diabetes Res Clin Pract Article Elsevier B.V. 2020-05 2020-04-10 /pmc/articles/PMC7151403/ /pubmed/32283128 http://dx.doi.org/10.1016/j.diabres.2020.108146 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Pal, Rimesh Bhadada, Sanjay K. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title | Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title_full | Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title_fullStr | Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title_full_unstemmed | Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title_short | Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? |
| title_sort | should anti-diabetic medications be reconsidered amid covid-19 pandemic? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151403/ https://www.ncbi.nlm.nih.gov/pubmed/32283128 http://dx.doi.org/10.1016/j.diabres.2020.108146 |
| work_keys_str_mv | AT palrimesh shouldantidiabeticmedicationsbereconsideredamidcovid19pandemic AT bhadadasanjayk shouldantidiabeticmedicationsbereconsideredamidcovid19pandemic |